-
-
-
-
-
-
-
Galera Therapeutics (GRTX) Expands Commercial Leadership Team
-
-
-
-
-
-
-
Galera Announces Presentation of Supplemental Analysis of Phase 3 ROMAN Trial at European Congress on Head and Neck Oncology
-
-
-
-
-
-
-
Galera Therapeutics (GRTX) Announces FDA Acceptance and Priority Review of Avasopasem NDA for Radiotherapy-Induced Severe Oral Mucositis
-
-
14,982 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

